drugset / Trial / NCT04480359
Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Bawei Shenqi Pill is effective in the treatment of active ankylosing spondylitis (AS).
Timeline
- Start
- 2017-10-01
- Primary completion
- 2020-08-30
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bawei Shenqi Pill | Traditional medicine (herbal / TCM) | 5.1 g | Oral |
| Comparator | Meloxicam | Small molecule | 7.5 mg | Oral |